Results 1 to 10 of about 3,189,219 (271)

The Role of Iron Chelation Therapy in Colorectal Cancer: A Systematic Review on Its Mechanisms and Therapeutic Potential [PDF]

open access: yesCancer Medicine
Background Despite significant therapeutic advancements in recent decades, colorectal cancer (CRC) continues to exhibit high rates of mortality and morbidity.
Gihani Vidanapathirana   +4 more
doaj   +3 more sources

Advances in iron chelation therapy: transitioning to a new oral formulation [PDF]

open access: yesDrugs in Context, 2017
Iron overload is a concern for patients who require repeated red-blood-cell transfusions due to conditions such as sickle cell disease, thalassemia, or myelodysplastic syndromes.
Nirmish R Shah
doaj   +3 more sources

MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY [PDF]

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2017
Over recent decades we have been fortunate to witness the advent of new technologies and of an expanded knowledge and application of chelation therapies to the benefit of patients with iron overload.
Emanuele Angelucci   +3 more
doaj   +5 more sources

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases [PDF]

open access: yesPharmaceuticals, 2018
Iron chelation has been introduced as a new therapeutic concept for the treatment of neurodegenerative diseases with features of iron overload. At difference with iron chelators used in systemic diseases, effective chelators for the treatment of ...
Marco T. Nuñez, Pedro Chana-Cuevas
doaj   +4 more sources

Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy. [PDF]

open access: yesJ Clin Med, 2023
Limited data regarding erythrocytapheresis in children, adolescents, and young adults have been published. The aim of this study was to evaluate erythrocytapheresis, either as a standalone therapy or in combination with iron chelation therapy, in ...
van Hattem J   +5 more
europepmc   +4 more sources

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions

open access: yesJournal of Blood Medicine, 2015
Antoine N Saliba, Afif R Harb, Ali T Taher Department of Internal Medicine, Division of Hematology/Oncology, American University of Beirut, Beirut, Lebanon Abstract: Transfusional iron overload is a major target in the care of patients with transfusion ...
Saliba AN, Harb AR, Taher AT
doaj   +3 more sources

Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia [PDF]

open access: yesFrontiers in Pediatrics, 2022
Study backgroundThalassemia is the commonest genetic blood disorder in Malaysia which requires life-long blood transfusions. From a total of 7,984 thalassemia patients in Malaysia, adolescent age group account for the highest number of patients (2,680 ...
Rafaa Mohamed   +3 more
doaj   +2 more sources

2D-ultrathin MXene/DOXjade platform for iron chelation chemo-photothermal therapy

open access: yesBioactive Materials, 2022
An increased demand for iron is a hallmark of cancer cells and is thought necessary to promote high cell proliferation, tumor progression and metastasis. This makes iron metabolism an attractive therapeutic target.
Yunjie Xu   +17 more
doaj   +3 more sources

Cardiac iron overload evaluation in thalassaemic patients using T2* magnetic resonance imaging following chelation therapy: a multicentre cross-sectional study

open access: yesHematology, Transfusion and Cell Therapy, 2023
Introduction: Magnetic resonance imaging (MRI) T2* technique is used to assess iron overload in the heart, liver and pancreas of thalassaemic patients. Optimal iron chelation and expected tissue iron response rates remain under investigation.
Eduardo Cerello Chapchap   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy